Pretreatment serum interferon gamma inducible protein-10 as biomarker of fibrosis and predictor of virological response in genotype 4 hepatitis C virus infection.

MLA

Khalifa, K. A., et al. “Pretreatment Serum Interferon Gamma Inducible Protein-10 as Biomarker of Fibrosis and Predictor of Virological Response in Genotype 4 Hepatitis C Virus Infection.” Acta Gastro-Enterologica Belgica, vol. 77, no. 4, Dec. 2014, pp. 401–07. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=25682629&authtype=sso&custid=ns315887.

APA

Khalifa, K. A., Radwan, W. M., Attallah, K. M., Hosney, H., & Eed, E. M. (2014). Pretreatment serum interferon gamma inducible protein-10 as biomarker of fibrosis and predictor of virological response in genotype 4 hepatitis C virus infection. Acta Gastro-Enterologica Belgica, 77(4), 401–407.

Chicago

Khalifa, K A, W M Radwan, K M Attallah, H Hosney, and E M Eed. 2014. “Pretreatment Serum Interferon Gamma Inducible Protein-10 as Biomarker of Fibrosis and Predictor of Virological Response in Genotype 4 Hepatitis C Virus Infection.” Acta Gastro-Enterologica Belgica 77 (4): 401–7. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=25682629&authtype=sso&custid=ns315887.